Researcher
Lucas Van Bortel
- Disciplines:Cardiac and vascular medicine not elsewhere classified, Cardiology, Drug discovery and development not elsewhere classified, Clinical trials, Vascular diseases, Compound screening, In vitro testing, Non-clinical studies, Small molecules, Other clinical sciences not elsewhere classified
Affiliations
- Department of Pharmacology (Department)
Member
From1 Oct 2000 → 30 Sep 2015
Projects
1 - 1 of 1
- Phenotyping atherosclerosis: morphological and functional research of the intima and media layer of the carotid and femoral arteryFrom1 Jan 2009 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 263
- One-year evolution of sleep quality in older users of benzodiazepines: a longitudinal cohort study in Belgian nursing home residents(2014)
Authors: Monique Elseviers, Lucas Van Bortel
Pages: 677 - 682 - Rectal and sublingual administration of tacrolimus: a single-dose pharmacokinetic study in healthy volunteers(2014)
Authors: Frank Stifft, Floris Vanmolkot, Ingrid Scheffers, Lucas Van Bortel, Cees Neef, Maarten Christiaans
Pages: 996 - 1004 - Blood pressure and mortality risk, need to revise current risk stratification?(2014)
Authors: Lucas Van Bortel
Pages: 978 - 980 - Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors(2013)
Authors: Lian Engelen, Isabel Ferreira, Coen D Stehouwer, Pierre Boutouyrie, Stéphane Laurent, the Reference Values Arterial Measurements Collaboration, Sebastian Vermeersch, Lucas Van Bortel, Caroline Van daele
Pages: 2368 - U30 - Safety and pharmacokinetics of single and multiple oral doses of MK-8742, an HCV NS5A inhibitor, in healthy subjects(2013)Volume: 58
Authors: Eric Mangin, Wendy W Yeh, Luzelena Caro, Concetta Lipardi, Anna Mitselos, Iain P Fraser, Patricia Jumes, Xiaobi Huang, Daniel Dreyer, Lucas Van Bortel, et al.
Pages: 444A - 444A - The development and test of an intervention to improve ADR screening in nursing homes(2013)
Authors: TINNE DILLES, Lucas Van Bortel, Monique Elseviers
Pages: 379.e1 - 379.e6 - Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics: results from single oral dose studies in healthy volunteers(2013)
Authors: S Aubrey Stoch, Stefan Zajic, Julie A Stone, Deborah L Miller, Lucas Van Bortel, Kenneth C Lasseter, Barnali Pramanik, Caroline Cilissen, Qi Liu, Lida Liu, et al.
Pages: 1240 - 1254 - Retrospective analysis of metastatic renal cell cancer patients treated with sunitinib and the role of possible interactions(2013)Volume: 76
Authors: VIBEKE KRUSE, A De Both, N Beck, Lucas Van Bortel, Simon Van Belle, Sylvie Rottey
Pages: 834 - 834 - Effect of multiple-dose diltiazem on the pharmacokinetics of the renin inhibitor ACT-077825(2013)
Authors: Jasper Dingemanse, Laurent B Nicolas, Lucas Van Bortel
Pages: 113 - 119 - Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies(2012)
Authors: Daniel Lemogoum, William Ngatchou, Christophe Janssen, Marc Leeman, Lucas Van Bortel, Pierre Boutouyrie, Jean Paul Degaute, Philippe Van de Borne
Pages: 123 - 128